Disclosed are compounds of Formula I, Formula II, and Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
申请公布号
EP2741746(A4)
申请公布日期
2014.12.31
申请号
EP20120822366
申请日期
2012.08.06
申请人
GLAXOSMITHKLINE LLC
发明人
BASKARAN, SUBRAMANIAN;GRIMES, RICHARD, MARTIN;KAZMIERSKI, WIESLAW, MIIECZYSLAW;LEIVERS, MARTIN, ROBERT